177 related articles for article (PubMed ID: 6601060)
1. Efficacy of human hyperimmune globulin in prevention of Haemophilus influenzae type b disease in infant rats.
Ambrosino D; Schreiber JR; Daum RS; Siber GR
Infect Immun; 1983 Feb; 39(2):709-14. PubMed ID: 6601060
[TBL] [Abstract][Full Text] [Related]
2. Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin.
Santosham M; Reid R; Ambrosino DM; Wolff MC; Almeido-Hill J; Priehs C; Aspery KM; Garrett S; Croll L; Foster S
N Engl J Med; 1987 Oct; 317(15):923-9. PubMed ID: 2442610
[TBL] [Abstract][Full Text] [Related]
3. Passive immunization against disease due to Haemophilus influenzae type b: concentrations of antibody to capsular polysaccharide in high-risk children.
Ambrosino DM; Landesman SH; Gorham CC; Siber GR
J Infect Dis; 1986 Jan; 153(1):1-7. PubMed ID: 3484503
[TBL] [Abstract][Full Text] [Related]
4. Haemophilus influenzae type b infection in childhood: history of bacteremia and antigenemia.
La Scolea LJ; Rosales SV; Ogra PL
Infect Immun; 1985 Dec; 50(3):753-6. PubMed ID: 3877691
[TBL] [Abstract][Full Text] [Related]
5. Management of recurrent invasive Haemophilus influenzae infection.
Fruchter L; Insel R
Am J Dis Child; 1981 Oct; 135(10):927-9. PubMed ID: 6975037
[TBL] [Abstract][Full Text] [Related]
6. Anticapsular antibody requirements for protection against experimental Haemophilus influenzae type b bacteremia after splenectomy.
Rubin LG
Infect Immun; 1988 Apr; 56(4):984-6. PubMed ID: 3257941
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of Haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of age.
Lepow ML; Samuelson JS; Gordon LK
J Pediatr; 1985 Feb; 106(2):185-9. PubMed ID: 3871477
[TBL] [Abstract][Full Text] [Related]
8. Fetal-neonatal passive immunization against Hemophilus influenzae, type b.
Amstey MS; Insel R; Munoz J; Pichichero M
Am J Obstet Gynecol; 1985 Nov; 153(6):607-11. PubMed ID: 3877464
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial activity of a human monoclonal antibody to haemophilus influenzae type B capsular polysaccharide.
Hunter KW; Fischer GW; Hemming VG; Wilson SR; Hartzman RJ; Woody JN
Lancet; 1982 Oct; 2(8302):798-9. PubMed ID: 6126667
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease.
Siber GR; Thompson C; Reid GR; Almeido-Hill J; Zacher B; Wolff M; Santosham M
J Infect Dis; 1992 Jun; 165 Suppl 1():S129-33. PubMed ID: 1588146
[TBL] [Abstract][Full Text] [Related]
11. Haemophilus influenzae type b polysaccharide vaccines.
Granoff DM; Cates KL
J Pediatr; 1985 Sep; 107(3):330-6. PubMed ID: 3897497
[No Abstract] [Full Text] [Related]
12. Evaluation of the protective efficacy of Haemophilus influenzae type b vaccines in an animal model.
Halsey NA; Johansen TL; Bowman LC; Glode MP
Infect Immun; 1983 Mar; 39(3):1196-200. PubMed ID: 6601621
[TBL] [Abstract][Full Text] [Related]
13. Further studies of the role of noncapsular antibody in protection against experimental Haemophilus influenzae type b bacteremia.
Shenep JL; Munson RS; Barenkamp SJ; Granoff DM
Infect Immun; 1983 Oct; 42(1):257-63. PubMed ID: 6604698
[TBL] [Abstract][Full Text] [Related]
14. Decreased protective efficacy of reduced and alkylated human immune serum globulin in experimental infection with Haemophilus influenzae type b.
Schreiber JR; Barrus VA; Siber GR
Infect Immun; 1985 Jan; 47(1):142-8. PubMed ID: 3871195
[TBL] [Abstract][Full Text] [Related]
15. Effect of complement depletion on anticapsular-antibody-mediated immunity to experimental infection with Haemophilus influenzae type b.
Schreiber JR; Basker CJ; Siber GR
Infect Immun; 1987 Nov; 55(11):2830-3. PubMed ID: 3499398
[TBL] [Abstract][Full Text] [Related]
16. Postvaccination susceptibility to invasive Haemophilus influenzae type b disease in infant rats.
Sood SK; Schreiber JR; Siber GR; Daum RS
J Pediatr; 1988 Nov; 113(5):814-9. PubMed ID: 3263486
[TBL] [Abstract][Full Text] [Related]
17. Preparation of human hyperimmune globulin to Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidis.
Siber GR; Ambrosino DM; McIver J; Ervin TJ; Schiffman G; Sallan S; Grady GF
Infect Immun; 1984 Jul; 45(1):248-54. PubMed ID: 6429048
[TBL] [Abstract][Full Text] [Related]
18. Functional activities of human antibody induced by the capsular polysaccharide or polysaccharide-conjugate vaccines against Haemophilus influenzae type b.
Deveikis A; Ward J; Kim KS
Vaccine; 1988 Feb; 6(1):14-8. PubMed ID: 3258459
[TBL] [Abstract][Full Text] [Related]
19. Circulating polyribophosphate in Hemophilus influenzae, type b meningitis. Correlation with clinical course and antibody response.
O'Reilly RJ; Anderson P; Ingram DL; Peter G; Smith DH
J Clin Invest; 1975 Oct; 56(4):1012-22. PubMed ID: 1099117
[TBL] [Abstract][Full Text] [Related]
20. Capsular polysaccharide of Haemophilus influenzae type b as a vaccine.
Parke JC
Pediatr Infect Dis J; 1987 Aug; 6(8):795-8. PubMed ID: 3313244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
